MEI XUE: Open Payments
NPI 1902233414 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 40 payments from 10 companies in 2025. Trend: 2023 $592 · 2024 $986 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 11 | $211 |
| AstraZeneca Pharmaceuticals LP | 10 | $204 |
| Novo Nordisk Inc | 4 | $79 |
| ALK-Abello, Inc | 3 | $73 |
| Exact Sciences Corporation | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Corcept Therapeutics | 1 | $27 |
| ABBVIE INC. | 1 | $25 |
Products named: FARXIGA, Ozempic, Odactra, Cologuard Collection Kit, ZORYVE, AIRSUPRA, Kerendia, Korlym.
Industry payments across GA — which companies pay providers there.
